Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
ETS1 Function in Leukemia and Lymphoma
Rebecca A. Luchtel
*
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'ETS1 Function in Leukemia and Lymphoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Hematologic Malignancy
100%
Cancer
100%
Leukemia
100%
Cell Function
50%
Cell Maturation
50%
Proto Oncogene
50%
Oncogene
50%
Carcinogenesis
50%
Enhancer Region
50%
Cell Growth
50%
Acute Lymphoblastic Leukemia
50%
Diffuse Large B-Cell Lymphoma
50%
B Cell
50%
Adult T-Cell Leukemia/Lymphoma
50%
Lymphoid Cell
50%
T Cell
50%
Cancer Types
50%
Natural Killer Cell
50%
Transcription Factors
50%
Tumor Suppressor Protein
50%
Keyphrases
Leukemia
100%
Lymphoma
100%
ETS1
100%
Hematological Malignancies
20%
Malignancy
20%
Cancer Types
10%
B Cells
10%
Cell-to-cell
10%
Growth Differentiation
10%
Transcription Factor
10%
Natural Killer Cells
10%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
10%
Lymphoid Cells
10%
Therapeutic Targeting
10%
T Cells
10%
Signal Response
10%
Transcriptional Regulation
10%
Dysregulation
10%
Cell Development
10%
Cell Function
10%
Cell Growth
10%
Oncogene
10%
Response to Stimulus
10%
Hematological Cancer
10%
Tumor Suppressor
10%
Cellular Context
10%
Transcriptional Program
10%
Transcriptional Complex
10%
Solid Cancer
10%
Aberrant Expression
10%
Oncogenic Pathways
10%
Chromosomal Amplification
10%
Binding Complex
10%
Transcriptional Targets
10%
Diffuse Large B-cell Lymphoma (DLBCL)
10%
Adult T-cell Leukemia
10%
Target-based Approach
10%
Complex Target
10%
Viral Interaction
10%
ETS Proto-oncogene 1
10%
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Hematologic Malignancy
100%
Malignant Neoplasm
50%
T Cell Leukemia
50%
Tumor Suppressor Protein
50%
Diffuse Large B Cell Lymphoma
50%
Carcinogenesis
50%
Transcription Factors
50%
Acute Lymphoblastic Leukemia
50%
Biochemistry, Genetics and Molecular Biology
ETS1
100%
T Cell
30%
B Cell
20%
Oncogene
10%
Tumor Suppressor Protein
10%
Cell Function
10%
Cell Maturation
10%
Enhancer Region
10%
Proto Oncogene
10%
Transcription Factors
10%
Carcinogenesis
10%
Cell Growth
10%
Natural Killer Cell
10%